Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients
Clinical trial NCT00245466 · TERMINATED
Trial details
- NCT number
- NCT00245466
- Sponsor
- Ferring Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-10-01
- Primary completion
- 2006-03-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.